Literature DB >> 15929761

Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver Disease.

Jaana Latvala1, Johanna Hietala, Heidi Koivisto, Kimmo Järvi, Petra Anttila, Onni Niemelä.   

Abstract

OBJECTIVES: Excessive alcohol consumption is associated with the generation of antibodies against neoantigens induced by ethanol metabolism. However, the associations between such immune responses, ethanol consumption, and liver injury remain unclear.
METHODS: Eight-six male alcoholics with (n=54) or without (n=32) liver disease, and 20 male volunteers (6 abstainers, 14 moderate drinkers) underwent clinical, morphological, and biochemical assessments of liver status and ethanol consumption.
RESULTS: Antiacetaldehyde adduct IgAs in both groups of alcoholics were significantly higher than those in the controls. Elevated IgGs occurred in patients with liver disease, whereas IgMs were high in the heavy drinkers without apparent liver disease. Liver disease patients had high levels of both proinflammatory (IL-2, IL-6, IL-8, TNF-alpha) and antiinflammatory (IL-10) cytokines, whereas those without liver disease showed elevated IL-6, IL-8, and IL-10 only. Ethanol consumption correlated significantly with antiadduct IgA and IL-6 levels, which also showed parallel changes upon abstinence.
CONCLUSIONS: Alcoholic liver disease is associated with the generation of IgAs and IgGs against acetaldehyde-derived antigens and enhanced levels of both pro- and antiinflammatory cytokines, whereas elevated IgA, IL-6, and IL-10 characterize alcoholics without liver disease. These data suggest that immunological mechanisms may play a role in the sequence of events leading to liver disease in some patients with excessive drinking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929761     DOI: 10.1111/j.1572-0241.2005.41509.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  26 in total

1.  Estrogen suppresses heptatic IκB expression during short-term alcohol exposure.

Authors:  Eric G Lee; Bethany M Mickle-Kawar; Lester A Reinke; Randle M Gallucci
Journal:  Inflamm Res       Date:  2012-06-06       Impact factor: 4.575

2.  The role of ethanol metabolism in development of alcoholic steatohepatitis in the rat.

Authors:  Martin J Ronis; Soheila Korourian; Michael L Blackburn; Jamie Badeaux; Thomas M Badger
Journal:  Alcohol       Date:  2010-01-29       Impact factor: 2.405

3.  Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.

Authors:  Heidi Koivisto; Johanna Hietala; Petra Anttila; Onni Niemelä
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

4.  Does Genetic Loss of Immunoglobulin A Have No Impact on Alcoholic Liver Disease?

Authors:  Yuan Li; Wen-Xing Ding
Journal:  Alcohol Clin Exp Res       Date:  2016-11-07       Impact factor: 3.455

5.  Acute renal dysfunction in patients with alcoholic hepatitis.

Authors:  Robin Arora; Shweta Kathuria; Nishant Jalandhara
Journal:  World J Hepatol       Date:  2011-05-27

6.  Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis.

Authors:  Courtney S Schaffert; Michael J Duryee; Robert G Bennett; Amy L DeVeney; Dean J Tuma; Peter Olinga; Karen C Easterling; Geoffrey M Thiele; Lynell W Klassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

Review 7.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

8.  Toll-like receptors in the pathogenesis of alcoholic liver disease.

Authors:  Jan Petrasek; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Gastroenterol Res Pract       Date:  2010-08-17       Impact factor: 2.260

9.  Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities.

Authors:  A Gonzalez-Quintela; R Alende; F Gude; J Campos; J Rey; L M Meijide; C Fernandez-Merino; C Vidal
Journal:  Clin Exp Immunol       Date:  2007-11-15       Impact factor: 4.330

10.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

Authors:  Nicholas C Boetticher; Craig J Peine; Paul Kwo; Gary A Abrams; Tushar Patel; Bashar Aqel; Lisa Boardman; Gregory J Gores; William S Harmsen; Craig J McClain; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2008-09-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.